MoneyWorks4Me

USFDA commences inspection at Indoco Remedies’ Goa Plant I

18 Jan 2019 Evaluate

US Food and Drug Administration (USFDA) has commenced inspection at Indoco Remedies’ Goa Plant I (Solid oral facility) since January 17, 2019. Inspection of Goa Plant II (Sterile facility) was completed from November14- 21, 2018.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..